Moreover, these patients had dramatically slower dissociation rates of TTR tetramers (3). Kelly and colleagues subsequently found numerous, structurally distinct, small molecules that kinetically stabilized the quaternary structure of the TTR tetramer, thereby inhibiting the formation of amyloid fibrils.
moreover, significant differences in these prespecified key secondary endpoints were also observed after month 6. The overall relative risk of mortality was reduced by 33%, and there was a 13% decrease in absolute risk reduction with a number needed to treat of 7.5 to prevent 1 death over the 
